Ambu (547A) Stock Price & Analysis

2 Followers

547A Stock Chart & Stats

€11.60-€0.25(-2.11%)

At close: Nov 06 5:30 PM GMT+1

Day’s Range: EUR 11.60 - EUR 11.86
52-Week Range: EUR 7.76 - EUR 12.13
Previous Close: EUR 11.85
Volume: N/A
Average Volume (3M): 17
Market Cap: EUR 3.11B
Enterprise Value: EUR 16.13B
Total Cash (Recent Filing): EUR 640.00M
Total Debt (Recent Filing): EUR 554.00M
Price to Earnings (P/E): 35.9
Beta: 0.55
Next Earnings: Jan 28, 2027 (Est.)
EPS Estimate: 0.12
Next Dividend Ex-Date: N/A
Dividend Yield: 0.50%

Ambu News

Ambu Earnings Call Highlights Strong Growth and Innovation

Ambu A/S Class B (($DK:AMBU.B)) has held its Q4 earnings call. Read on for the main highlights of the call. Ambu’s earnings call conveyed a strongly optimistic message, led by

3d agoAMBFF 547A

Ambu downgraded to Neutral from Buy at UBS

UBS downgraded Ambu (AMBFF) to Neutral from Buy with a price target of DKK 72, down from DKK 96. A sustained re-rating of the shares is unlikely until the company’s

1M agoAMBFF 547A

Ambu A/S Earnings Call: Endoscopy Drives Growth

Ambu A/S Class B (($DK:AMBU.B)) has held its Q3 earnings call. Read on for the main highlights of the call. Ambu A/S Class B’s latest earnings call struck a cautiously

2M agoAMBFF 547A

Is AMBFF a Buy, Before Earnings?

Ambu A/S Class B (AMBFF) is scheduled to report 3rd quarter earnings on 08/26/2026. Regarding Q3 estimates, Wall Street analysts expect Ambu A/S Class B to post earnings of DKK0.62

2M agoAMBFF 547A

Ambu downgraded to Sell from Hold at Danske Bank

Danske Bank downgraded Ambu (AMBFF) to Sell from Hold with a price target of DKK 58, down from DKK 70. The firm is more cautious on the company’s near-term outlook

4M agoAMBFF 547A

AMBFF Upcoming Earnings Report: What to Expect?

Ambu A/S Class B (AMBFF) is scheduled to report 1st quarter earnings on 02/04/2026. Regarding Q1 estimates, Wall Street analysts expect Ambu A/S Class B to post earnings of DKK0.48

9M agoAMBFF 547A

Ambu A/S Reports Strong Q4 Growth and Strategic Advances

Ambu A/S Class B ( ($AMBFF) ) has released its Q4 earnings. Here is a breakdown of the information Ambu A/S Class B presented to its investors. Ambu A/S is

1y agoAMBFF 547A

Ambu A/S Earnings Call: Growth Amid Challenges

Ambu A/S Class B (($DK:AMBU.B)) has held its Q4 earnings call. Read on for the main highlights of the call. Ambu A/S Class B’s recent earnings call highlighted a robust

1y agoAMBFF 547A

Ambu A/S Reports Strong Q3 Growth and Strategic Advances

Ambu A/S Class B ( ($AMBFF) ) has released its Q3 earnings. Here is a breakdown of the information Ambu A/S Class B presented to its investors. Ambu A/S Class

1y agoAMBFF 547A

AMBFF Upcoming Earnings Report: What to Expect?

Ambu A/S Class B (AMBFF) is scheduled to report 3rd quarter earnings on 08/22/2025. Regarding Q3 estimates, Wall Street analysts expect Ambu A/S Class B to post earnings of DKK0.55

1y agoAMBFF 547A

Ambu initiated with a Buy at UBS

UBS analyst Thyra Lee initiated coverage of Ambu (AMBFF) with a Buy rating and DKK 147 price target The company is set to deliver mid-teens sales and mid-20s earnings growth,

1y agoAMBFF 547A

Ambu A/S Reports Strong Q2 Growth and Innovation

Ambu A/S Class B ( ($AMBFF) ) has released its Q2 earnings. Here is a breakdown of the information Ambu A/S Class B presented to its investors. Ambu A/S is

1y agoAMBFF 547A

Ambu A/S Reports Strong Q1 2024/25 Results

Ambu A/S Class B ( ($AMBFF) ) has released its Q1 earnings. Here is a breakdown of the information Ambu A/S Class B presented to its investors. Ambu A/S, a

1y agoAMBFF 547A

547A FAQ

What was Ambu’s price range in the past 12 months?

Ambu lowest stock price was €7.76 and its highest was €12.13 in the past 12 months.

What is Ambu’s market cap?

Ambu’s market cap is €3.11B.

When is Ambu’s upcoming earnings report date?

Ambu’s next earnings report is estimated for Jan 28, 2027 (not yet confirmed), which is in 78 days.

How were Ambu’s earnings last quarter?

Ambu released its earnings results on Nov 05, 2026. The company reported €0.126 earnings per share for the quarter, beating the consensus estimate of €0.115 by €0.01.

Is Ambu overvalued?

According to Wall Street analysts Ambu’s price is currently Overvalued.

Does Ambu pay dividends?

Ambu does not currently pay dividends.

What is Ambu’s EPS estimate?

Ambu’s EPS estimate is 0.12.

How many shares outstanding does Ambu have?

Ambu has 234,974,400 shares outstanding.

What happened to Ambu’s price movement after its last earnings report?

Ambu reported an EPS of €0.126 in its last earnings report, beating expectations of €0.115. Following the earnings report the stock price went up 3.856%.

Which hedge fund is a major shareholder of Ambu?

Currently, no hedge funds are holding shares in DE:547A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Ambu

Established in 1937 and headquartered in Ballerup, Denmark, Ambu A/S is a global medical technology company specializing in the design, manufacture, and sale of advanced medical devices. The company serves hospitals, clinics, and emergency services worldwide, providing essential healthcare solutions across key disciplines such as visualization, anesthesia, and patient monitoring and diagnostics. Their extensive product portfolio includes sophisticated endoscopy equipment like bronchoscopes and dedicated monitors. For neurology, Ambu offers EEG and EMG electrodes, as well as tools for EMG-guided injections and intraoperative monitoring systems. Cardiology solutions feature ECG electrodes. A substantial portion of their offerings is dedicated to airway management and anesthesia, comprising specialized bronchoscopes, video laryngoscopes, various intubation tubes (double and single lumen), endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitation devices. Additionally, Ambu provides critical emergency and training products, including extrication collars, CPR breathing barriers, and training manikins.

Ambu (547A) Earnings & Revenues

Historic Earnings Reports

547A Company Deck

547A Earnings Call

Q4 2026

0:00 / 0:00

Earnings Call SentimentPositive

The call was strongly optimistic, supported by 10.1% full-year organic growth, 13.9% Q4 growth, accelerating Endoscopy Solutions performance, a broad innovation pipeline, strong market share, and maintained long-term targets. The main challenges were limited A&PM and anesthesia growth, flat gross margin, tariff and TIMS-related costs, competitive pricing pressure in Urology, gradual product-launch ramps, and temporarily lower cash conversion. Overall, the highlights significantly outweighed the lowlights.

View all DE:547A earnings summaries

547A Stock 12 Month Forecast

Average Price Target

EUR 9.63▼(-16.97% Downside)

Past 12 Months12 Month ForecastFeb2026Nov2026

HighEUR 9.63

AverageEUR 9.63

LowEUR 9.63

Detailed Analyst Forecast >

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	15	1	6
Technical Analysis	3	1	6
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to DE:547A
Company	Price & Change	Follow
AMBFFAmbu
TFXTeleflex
CNMDConmed
MMSIMerit Medical Systems
PODDInsulet
ATRCAtricure
INGNInogen

Compare DE:547A Stocks >

Ownership Overview

12.58% Mutual Funds
<0.01% Other Institutional Investors
82.64% Public Companies and Individual Investors

Detailed Ownership Overview >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

547A Stock Chart & Stats

Ambu News

Ambu Earnings Call Highlights Strong Growth and Innovation

Ambu downgraded to Neutral from Buy at UBS

Ambu A/S Earnings Call: Endoscopy Drives Growth

Is AMBFF a Buy, Before Earnings?

Ambu downgraded to Sell from Hold at Danske Bank

AMBFF Upcoming Earnings Report: What to Expect?

Ambu A/S Reports Strong Q4 Growth and Strategic Advances

Ambu A/S Earnings Call: Growth Amid Challenges

Ambu A/S Reports Strong Q3 Growth and Strategic Advances

AMBFF Upcoming Earnings Report: What to Expect?

Ambu initiated with a Buy at UBS

Ambu A/S Reports Strong Q2 Growth and Innovation

Ambu A/S Reports Strong Q1 2024/25 Results

547A FAQ

Company Description

Ambu

Ambu (547A) Earnings & Revenues

547A Company Deck

547A Earnings Call

Earnings Call Sentiment|Positive

547A Stock 12 Month Forecast

Average Price Target

Technical Analysis

Overall Consensus

Similar Stocks

Ownership Overview

Popular Stocks

Become an Expert with TipRanks Premium

Earnings Call SentimentPositive